Oxytocinergic neurons in rat hypothalamus. Dexamethasone-reversible increase in their corticotropin-releasing factor-41-like immunoreactivity in response to osmotic stimulation.
Recent results have demonstrated altered corticotropin-releasing factor (CRF)-41 content of the neurointermediate lobe (NIL) of the pituitary gland in response to various manipulations including osmotic stimulation. This study was undertaken to determine whether changes in CRF-41 content of the NIL are accompanied by changes in intensity of CRF-41-like immunoreactivity (CRF-41-LI) of neurosecretory neurones of the hypothalamus in response to osmotic stimulation. Wistar rats of both sexes given either tap water ad libitum, 2% NaCl solution, or access to tap water was limited to 20 min daily, for 7 days. Subsets of rats from each group were adrenalectomized (ADX) or treated with dexamethasone (DEX). Thirty-six hour before perfusion with fixative consisting of buffered formaldehyde and picric acid, animals received 75 micrograms colchicine i.c.v. Forty micrometer thick vibratome sections were stained for CRF-LI, arginine vasopressin (AVP-LI) and oxytocin (OXY-LI) using the avidin-biotin-peroxidase complex method. In response to both types of osmotic stimulation magnocellular neurones of the paraventricular (PVN) and supraoptic nuclei (SON) showed increased CRF-LI, AVP-LI and OXY-LI, while CRF-LI of parvocellular perikarya of the PVN decreased. The enhanced CRF-LI seemed to appear in a subset of magnocellular neurones with OXY-LI but not AVP-LI. Increased staining intensities were also observed in magnocellular neurones in ADX rats challenged osmotically. In contrast, systemic DEX administration, as well as implantation of DEX in the area on the SON, sharply attenuated CRF-LI but not AVP-LI or OXY-LI of magnocellular neurones in osmotically stimulated rats.(ABSTRACT TRUNCATED AT 250 WORDS)
Dohanics
J
J
Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest.
Kovacs
K J
KJ
Makara
G B
GB
D000315:Adrenalectomy; D000818:Animals; D001127:Arginine Vasopressin / Q000032:analysis; D003078:Colchicine; D003346:Corticotropin-Releasing Hormone / Q000032:analysis*; D003907:Dexamethasone / Q000494:pharmacology*; D004326:Drinking / Q000502:physiology; D005260:Female; D007031:Hypothalamus / Q000032:analysis* / Q000166:cytology / Q000187:drug effects; D007124:Immunoenzyme Techniques; D008297:Male; D009474:Neurons / Q000032:analysis* / Q000187:drug effects; D009997:Osmotic Pressure; D010121:Oxytocin / Q000032:analysis*; D051381:Rats; D011919:Rats, Inbred Strains
D001127:Arginine Vasopressin; D010121:Oxytocin; D003907:Dexamethasone; D003346:Corticotropin-Releasing Hormone; D003078:Colchicine